Rapid Screening Technology
The development of fast, accurate, and cheap COVID-19 detection products will decentralize the screening process and reduce the reliance on laboratories. The first OxLAMPTM RaViD Direct SARS-CoV-2 product was developed to facilitate rapid, portable, and accurate results in COVID-19 detection.
The OxLAMPTM test can deliver results in 20 minutes, with a sensitivity of 96% and a specificity of 99.9%, eliminating the need for laboratory processing. It has already received the CE-IVD mark in the EU and MHRA approval in the UK. Efforts are also made presently to submit it to the FDA for emergency authorization. The test is currently used at the London Heathrow airport and trialed at the Hong Kong International Airport to screen passengers.